Jlabs @华盛顿，直流儿童的Quickfire挑战

Awardees

algometrx.

这algometrx.Nociometer®是一种平台技术，可实现疼痛类型和强度的客观评估，使得开发专注于建立儿科化疗诱导的周围神经病变（CIPN）评估工具的新应用，其目的是允许早期检测和长期监测癌症治疗的显着发病率。

一致性医疗解决方案

一致性医疗解决方案，LLC提供基于装置的药物递送溶液，用于涉及注射微升体积剂量的应用。

Gabi SmartCare

Gabi SmartCare旨在使研究人员、医生和家长s with data driven health assessment to disrupt pediatric healthcare & improve children’s lives.

LifeSprout

LifeSprout’s injectable product portfolio is designed with the aim to offer immediate tissue restoration and regeneration that looks and behaves like natural tissue following pediatric oncologic reconstruction.

Areas of Interest

我们鼓励创新者在儿科肿瘤，儿科外科护理和流感上工作的创新者。具体的重点领域包括：

儿科肿瘤学

• Innovations in pediatric oncology port technologies
• 针对特异性特异性司机基因的药物
• Bedside, rapid tumor genetic testing

Pediatric Surgical Care

• 特异性特异性植入物，用于创伤和裂缝护理，包括生长脊柱和创伤骨科植入物
• Innovative treatment options for adolescent idiopathic scoliosis
• 治疗儿科患者的手术机器人

Influenza

• Pediatric-focused innovations in influenza
• 流感疫苗递送的新型解决方案
• Influenza pre-exposure including antivirals prophylaxis formulation

Applications will be accepted across:

• Pharmaceuticals
• Medical devices
• Consumer products
• Global public health
• Health technologies
• Cross-sector initiatives (an integration of one or more areas of focus mentioned above)

我们正在寻找什么

Submissions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria:

• Potential impact
• Uniqueness of solution & level of competition in the current market
• Quality & feasibility of the technology
• 团队可信度和能力
• Plans for utilizing JLABS @ Washington, DC

想法提交概述了华盛顿的创新生态系统的兴趣。

Why This Challenge Matters To Us

制定安全有效的药品，设备或消费品，使后代能够达到其全部潜力，需要儿童为中心的创新。孩子健康Innovation Leadership Department (CHILD) is Johnson & Johnson’s dedicated team workingto understand the safety and effectiveness of our medicines in children, and to accelerate policies受到最小患者的需求的推动。

We collaborate with the aim to change the paradigm for pediatric medical research to enable better-informed decisions by regulators and healthcare practitioners so all children can live longer, healthier and happier lives.

我们相信一个好主意可以来自任何地方，找到有可能为来自世界各地提供解决方案的新技术和创新技术。在一起，我们可以激发一个可以改变儿童健康轨迹的下一个好主意。

[1]这contracting entity is Children’s National at Walter Reed, LLC, a wholly owned subsidiary of Children’s National Health System.

About Johnson & Johnson Innovation

Johnson & Johnson Innovation, LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers; Johnson & Johnson Innovation|JLABS; Johnson & Johnson Innovation – JJDC, Inc.; and our business development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools and resources needed to help life science startups thrive, all with no strings attached. A Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. For more information about Johnson & Johnson Innovation, please visit:www.jnjinnovation.com.

关于约翰逊和约翰逊的创新 - Jlabs

Johnson & Johnson Innovation|JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS, we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS also produces campaigns to seek out the best science called QuickFire Challenges. For more information, visitwww.www.2574design.comor follow @JLABS.